CFR section

21 CFR 606.40(a)(1): Facilities

PART 606-CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS · Subpart C-Plant and Facilities

Key facts

Citation 21 CFR 606.40(a)(1)
Section Facilities
Part PART 606-CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
Subpart Subpart C-Plant and Facilities
Subchapter 21 CFR F Biologics
Product types cited Biologics, Drugs, General
Regulation text (excerpt) (1) Private and accurate examinations of individuals to determine their eligibility as blood donors.

At a glance

  • 100–999 Inspections citing this section
  • 1–9 Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA